1. NSAIDs: Old Acquaintance in the Pipeline for Cancer Treatment and Prevention─Structural Modulation, Mechanisms of Action, and Bright Future
   Sandra Ramos-Inza et al, 2021, Journal of Medicinal Chemistry CrossRef
2. The emerging role of hypoxia-inducible factor-2 involved in chemo/radioresistance in solid tumors
   Jiuda Zhao et al, 2015, Cancer Treatment Reviews CrossRef
3. CD44 targeting nanodrug based on chondroitin sulfate for melanoma therapy by inducing mitochondrial apoptosis pathways
   Yan Li et al, 2023, Carbohydrate Polymers CrossRef
4. Biocompatible Fe-Based Micropore Metal-Organic Frameworks as Sustained-Release Anticancer Drug Carriers
   Xin Leng et al, 2018, Molecules CrossRef
5. Cudraxanthone L inhibits gastric cancer by regulating the MAPK signalling and promoting FAS-mediated pathway
   Jiamei Zhang et al, 2021, Biomedicine & Pharmacotherapy CrossRef
6. Expression and Cellular Distribution of P-Glycoprotein and Breast Cancer Resistance Protein in Amyotrophic Lateral Sclerosis Patients
   Erwin A van Vliet et al, 2020, Journal of Neuropathology & Experimental Neurology CrossRef
7. Combinatorial therapeutic approach for treatment of oral squamous cell carcinoma
   Rituraj Bharadwaj et al, 2019, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
8. Celecoxib in Cancer Therapy and Prevention – Review
   Natalia Tołoczko-Iwaniuk et al, 2019, Current Drug Targets CrossRef
9. Diallyl trisulfide inhibits gastric cancer stem cell properties through ΔNp63/sonic hedgehog pathway
   Miaomiao Ge et al, 2023, Molecular Carcinogenesis CrossRef
10. Drug Repurposing in Gastric Cancer: Current Status and Future Perspectives
    Marina Leite et al, 2023, Hereditary Gastric and Breast Cancer Syndrome CrossRef